Immune System in Diabetic Kidney Disease
NCT07292493 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2026-02-23
Summary
Diabetes is a chronic condition marked by long-term elevated blood glucose levels. There are more types of diabetes; the majority of patients have type 1 or type 2 diabetes. Over long period of time, high blood sugar damages blood vessels and organs. One of the most common complications is diabetic kidney disease, which can slowly lead to kidney failure. People with this condition also have a much higher risk of heart and blood vessel diseases.
Newer research shows that the immune system, especially the complement system (a group of proteins that help defend the body), may also play a role in worsening kidney disease in diabetes. High blood sugar can activate these proteins, and they have been found in kidney tissue of patients with diabetic kidney disease.
The goal of this study is to find out how much the complement system contributes to kidney damage in diabetes, whether it affects different groups of patients differently, and whether it is linked to blood vessel health or the stage of kidney disease. The study will also assess if improved diabetes control is linked to reduced complement system activity.
Conditions
- Diabetes
- Diabetic Kidney Disease
- Complement System
Sponsors & Collaborators
-
University Medical Centre Ljubljana
lead OTHER
Principal Investigators
-
Miodrag Janić
Eligibility
- Min Age
- 40 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-01
- Primary Completion
- 2026-12-31
- Completion
- 2028-12-31
Countries
- Slovenia
Study Locations
More Related Trials
-
Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease
NCT06639529 ·Status: COMPLETED ·Phase: NA
-
Diabetic Patients With End-Stage Renal Disease
NCT00435786 ·Status: COMPLETED
-
Prediabetes in End Stage Renal Disease on Dialysis
NCT07337083 ·Status: COMPLETED
-
Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.
NCT01835678 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Analysis of Diabetic Kidney Disease Biopsies
NCT04029402 ·Status: RECRUITING
-
A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated
NCT03550378 ·Status: COMPLETED ·Phase: PHASE2
-
The Incretin Effect in Patients With Kidney Impairment
NCT01327378 ·Status: COMPLETED
-
Kidney Biopsy Indications in Type 2 Diabetes Patients
NCT04006028 ·Status: COMPLETED
-
EFFECT SGLT2 INHIBITORS ON CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY
NCT06288529 ·Status: COMPLETED
-
The Differential Effects of Diabetes Therapy on Inflammation
NCT02150707 ·Status: COMPLETED
-
Renal Mechanism of SGLT2 Inhibition
NCT05507892 ·Status: RECRUITING ·Phase: PHASE2
-
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
NCT06694558 ·Status: RECRUITING
-
Nitric Oxide (NO) Activity and Diabetic Nephropathy
NCT00136188 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe
NCT04589351 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
NCT02065791 ·Status: COMPLETED ·Phase: PHASE3
-
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
NCT04498156 ·Status: COMPLETED
-
Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
NCT05147896 ·Status: UNKNOWN ·Phase: NA
-
Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT01165268 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of SGLT-2 Inhibition on Hepatic Glucose and Energy Metabolism
NCT02558270 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effects of Empagliflozin on Arterial Wall Characteristics
NCT03639545 ·Status: UNKNOWN ·Phase: PHASE4
-
Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)
NCT05319990 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy
NCT05695573 ·Status: COMPLETED
-
Renal Impairment in Type 2 Diabetic Subjects
NCT00554450 ·Status: COMPLETED ·Phase: PHASE1
-
Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients
NCT06101901 ·Status: NOT_YET_RECRUITING
-
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
NCT00324675 ·Status: COMPLETED ·Phase: NA